349 related articles for article (PubMed ID: 25083955)
1. Epstein-Barr virus associated hemophagocytic lymphohistiocytosis in a rheumatic patient receiving abatacept therapy.
Dalal RS; LeGolvan MP; Stachurski DR; Goldberg LR
R I Med J (2013); 2014 Aug; 97(8):28-31. PubMed ID: 25083955
[TBL] [Abstract][Full Text] [Related]
2. Ileal mass-like lesion induced by Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a patient with aplastic anemia.
Min KW; Jung HY; Han HS; Hwang TS; Kim SY; Kim WS; Lim SD; Kim WY
APMIS; 2015 Jan; 123(1):81-6. PubMed ID: 25243347
[TBL] [Abstract][Full Text] [Related]
3. A case of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with severe cardiac complications.
Kawamura Y; Miura H; Matsumoto Y; Uchida H; Kudo K; Hata T; Ito Y; Kimura H; Yoshikawa T
BMC Pediatr; 2016 Oct; 16(1):172. PubMed ID: 27793118
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré syndrome and hemophagocytic lymphohistiocytosis in a patient with severe chronic active Epstein-Barr virus infection syndrome.
Takahashi K; Kunishige M; Shinohara M; Kubo K; Inoue H; Yoshino H; Asano A; Honda S; Matsumoto T; Mitsui T
Clin Neurol Neurosurg; 2005 Dec; 108(1):80-3. PubMed ID: 16311154
[TBL] [Abstract][Full Text] [Related]
5. Rapidly Fatal Hemophagocytic Lymphohistiocytosis Developing Within Six Days Following Deceased-Donor Renal Transplantation: Case Report.
Filippone EJ; Singh P; Frank AM; Gupta A; Farber JL
Transplant Proc; 2016 Nov; 48(9):3123-3127. PubMed ID: 27932162
[TBL] [Abstract][Full Text] [Related]
6. Poor outcomes of chronic active Epstein-Barr virus infection and hemophagocytic lymphohistiocytosis in non-Japanese adult patients.
Sonke GS; Ludwig I; van Oosten H; Baars JW; Meijer E; Kater AP; de Jong D
Clin Infect Dis; 2008 Jul; 47(1):105-8. PubMed ID: 18491961
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells.
Fox CP; Shannon-Lowe C; Gothard P; Kishore B; Neilson J; O'Connor N; Rowe M
Clin Infect Dis; 2010 Jul; 51(1):66-9. PubMed ID: 20504238
[TBL] [Abstract][Full Text] [Related]
8. Fatal Epstein-Barr virus infection in a case of familial hemophagocytic lymphohistiocytosis with syntaxin-11 mutation.
Albayrak M; Kaya Z; Yilmaz-Keskin E; Stadt UZ; Koçak U; Gürsel T
Turk J Pediatr; 2009; 51(4):371-4. PubMed ID: 19950846
[TBL] [Abstract][Full Text] [Related]
9. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
[TBL] [Abstract][Full Text] [Related]
10. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis.
Balamuth NJ; Nichols KE; Paessler M; Teachey DT
J Pediatr Hematol Oncol; 2007 Aug; 29(8):569-73. PubMed ID: 17762500
[TBL] [Abstract][Full Text] [Related]
11. [Hemophagocytic syndrome associated with Epstein-Barr virus. Presentation of a case and treatment in the Resuscitation Unit].
Figueiredo González O; Iglesias Fernández M; Río Gómez A; Ulibarrena Redondo C; Casas García ML
Rev Esp Anestesiol Reanim; 2014 Dec; 61(10):571-4. PubMed ID: 24468010
[TBL] [Abstract][Full Text] [Related]
12. Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies.
Brito-Zerón P; Bosch X; Pérez-de-Lis M; Pérez-Álvarez R; Fraile G; Gheitasi H; Retamozo S; Bové A; Monclús E; Escoda O; Moreno A; López-Guillermo A; Khamashta MA; Ramos-Casals M;
Semin Arthritis Rheum; 2016 Feb; 45(4):391-9. PubMed ID: 26277577
[TBL] [Abstract][Full Text] [Related]
13. [Research advance on Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
Wei Q; Wang Z
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1541-4. PubMed ID: 22169321
[TBL] [Abstract][Full Text] [Related]
14. Hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus in the central nervous system.
Magaki S; Ostrzega N; Ho E; Yim C; Wu P; Vinters HV
Hum Pathol; 2017 Jan; 59():108-112. PubMed ID: 27574808
[TBL] [Abstract][Full Text] [Related]
15. [Five adult cases of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis].
Abe Y; Shiratsuchi M; Nagasawa E; Ohtsuka R; Kiyasu J; Sada E; Idutsu K; Kotoh K; Nishimura J; Ohga S; Takayanagi R
Rinsho Ketsueki; 2010 Jan; 51(1):74-9. PubMed ID: 20134144
[TBL] [Abstract][Full Text] [Related]
16. Epstein barr virus hemophagocytic lymphohistiocytosis related to rituximab use and immunopathogenetic insights.
Papageorgiou SG; Tsiodras S; Siakallis G; Bazani E; Spathis A; Poulakou G; Korkolopoulou P; Panayiotides I; Pappa V
Pathol Res Pract; 2016 Dec; 212(12):1194-1198. PubMed ID: 28340951
[TBL] [Abstract][Full Text] [Related]
17. [Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis: Rarity and Severity in an Immunocompetent Adult].
Costa A; Paixão A; Santos H; Salvador F
Acta Med Port; 2019 Feb; 32(1):78-80. PubMed ID: 30753807
[TBL] [Abstract][Full Text] [Related]
18. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin.
Beutel K; Gross-Wieltsch U; Wiesel T; Stadt UZ; Janka G; Wagner HJ
Pediatr Blood Cancer; 2009 Aug; 53(2):184-90. PubMed ID: 19353621
[TBL] [Abstract][Full Text] [Related]
19. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
[TBL] [Abstract][Full Text] [Related]
20. Severe hemorrhagic coagulopathy with hemophagocytic lymphohistiocytosis secondary to Epstein-Barr virus-associated T-cell lymphoproliferative disorder.
Nawathe PA; Ravindranath TM; Satwani P; Baird JS
Pediatr Crit Care Med; 2013 May; 14(4):e176-81. PubMed ID: 23439459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
